← Back to Clinical Trials
Recruiting NCT07725003

NCT07725003 Telerehabilitation Based Motor Relearning Program and Telerehabilitation Based Conventional Physical Therapy in Stroke

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07725003
Status Recruiting
Phase —
Sponsor Riphah International University
Condition Stroke
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2025-06-05
Primary Completion 2026-08-06

Eligibility & Interventions

Sex All sexes
Min Age 40 Years
Max Age 70 Years
Study Type INTERVENTIONAL
Interventions
Telerehabilitation Based Motor Relearning ProgramConventional physical therapy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 30 participants in total. It began in 2025-06-05 with a primary completion date of 2026-08-06.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to compare the effects of telerehabilitation based motor relearning program and telerehabilitation based conventional physical therapy on motor function and balance in stroke patients.

Eligibility Criteria

Inclusion Criteria: \* Adults aged 40-70 years. * Male or female participants. * Diagnosed with ischemic or hemorrhagic stroke 3-12 months prior to enrollment. * Medically stable and cleared to participate in physical rehabilitation. * Mini-Mental State Examination (MMSE) score ≥24. * Able to understand and follow verbal instructions. * Have access to a smartphone, tablet, or computer with a stable internet connection for telerehabilitation sessions. * Willing and able to provide written informed consent. Exclusion Criteria: \* MMSE score \<24 or severe cognitive impairment. * Presence of other neurological disorders (e.g., Parkinson's disease or multiple sclerosis). * Uncontrolled hypertension or recent cardiac event. * Severe visual, auditory, or communication impairments that prevent participation. * Currently enrolled in another structured rehabilitation program. * Any musculoskeletal or medical condition that would interfere with safe participation in the intervention.

Contact & Investigator

Central Contact

Imran Amjad, phd

✉ imran.amjad@riphah.edu.pk

📞 +923324390125

Principal Investigator

Misbah Waris, phd

PRINCIPAL INVESTIGATOR

Riphah International University

Frequently Asked Questions

Who can join the NCT07725003 clinical trial?

This trial is open to participants of all sexes, aged 40 Years or older, up to 70 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07725003 currently recruiting?

Yes, NCT07725003 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.

Where is the NCT07725003 trial being conducted?

This trial is being conducted at Faisalabad, Pakistan.

Who is sponsoring the NCT07725003 clinical trial?

NCT07725003 is sponsored by Riphah International University. The principal investigator is Misbah Waris, phd at Riphah International University. The trial plans to enroll 30 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology